RecruitingNot ApplicableNCT07129148

Mobile Health and Wearable Devices for Diabetes Complication Management

Study on the Applicability of New Technologies for Diabetes Complication Management Based on Mobile Health and Wearable Devices

Sponsor

Second Xiangya Hospital of Central South University

Enrollment

6,000 participants

Start Date

Oct 1, 2025

Study Type

INTERVENTIONAL

Conditions

Diabetes Mellitus, Type 2 Diabetes Mellitus Complications

Summary

The value of intelligent lifestyle intervention for T2D and its complications has been initially explored, but evidence-based support for the effectiveness of related AI risk prediction models and intervention models remains to be confirmed. The primary objective of this study is to verify the effectiveness of an AI model for predicting the risk of T2D complications based on phenotype, laboratory indicators and wearable device indicators, and to explore the effect and applicability of an intelligent lifestyle intervention model combining wearable devices and smartphones in preventing T2D complications.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Device: "Professor Tang" WeChat Mini-program, Device: CGM, Smart Bracelet, "Professor Tang" WeChat Mini-program, and others for people with diabetes mellitus complications and diabetes mellitus, type 2. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.